ADA and triple-A syndrome: The detection of AAA using two enzyme-linked immunosorbent assay (ELISA) methods—IDKmonitor® Adalimumab free ADA (Immundiagnostik AG, Darmstadt, Germany) and LISA-TRACKER Duo Adalimumab (Theradiag, France)—was compared to the POC method, AFIAS Free Anti-Adalimumab (Boditech, Chuncheon, Republic of Korea).